לבטיראצטם דקסל 500

Country: ইস্রায়েল

ভাষা: হিব্রু

সূত্র: Ministry of Health

সক্রিয় উপাদান:

LEVETIRACETAM

থেকে পাওয়া:

DEXCEL PHARMA TECHNOLOGIES LTD

এটিসি কোড:

N03AX14

ফার্মাসিউটিকাল ফর্ম:

טבליה

রচনা:

LEVETIRACETAM 500 MG

প্রশাসন রুট:

פומי

প্রেসক্রিপশন টাইপ:

מרשם נדרש

Manufactured by:

DEXCEL LTD, ISRAEL

Therapeutic group:

LEVETIRACETAM

Therapeutic area:

LEVETIRACETAM

থেরাপিউটিক ইঙ্গিত:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

পণ্য সারাংশ:

א. התרופה האמורה תינתן לטיפול באפילפסיה. ב. מתן התרופה ייעשה לפי המלצת רופא מומחה בנוירולוגיה.

অনুমোদন তারিখ:

2018-03-31

তথ্য লিফলেট

(
)
"
-
1986
250
,
500 ,
750 ,
1000
,
(
Levetiracetam
)
250
,
500
,
750
1000
"
,
.
-
6
"
"
2
"
"
.
.
.
,
.
.
.
.
1
.
?

16
.

-
:

4
,
.

12
Juvenile myoclonic epilepsy
Idiopathic generalised epilepsy
.
:
.
2
.
:

)
(
(
)
(Pyrrolidone)
(
6
.)
: ,

.
.

,
.

/
.
-
.
.
.
:
,
,
,
,
.

) "
(
.

:
o
,
,
.
o
:
,
,
.
.
,
)
(
(
SCN8A
)
.
, - !
16
.
,
, , .
:

)
(
.
,
.

.
.
,
.
.)
(
.
,
.
.
,
,
,
.
,
.
.
.
.
,
.
.
.
,
.
-
1
(
23
) "
,
."
"
750
Sunset yellow (E110)
,
.
3
.
?
.
.
. .
)
(
.
-
2
.
.
,
.
.
.

.
.

.
,
.
:
,
,
,
,
.
,
.
.
.
,
.
,
.
! . . ,
.
4
.
,
.
.
.
:

,
.
)
(
.

,
,
(
s oedema
’
Quincke
)
.

,
(
)
(
DRESS
)
.

,
,
,
,
,
.
.

(
,
)
(
)
.

,
,
,
(
-
)
'
.

-
30%
(
)
.

,
,
(
)
,)
(
,
.
.
,
,
,
.
,
,
.
.
(
)
:


,
(
1-10
100
)
:

(
)

,
,
,
,

,
,
,
(
-
)
,

)
(


,
,
,
,


(
1-10
1,000
)
:

,


,
,
,
,
,
,
,
,
(
)

,
,)
(
/
(
)
,
)
(
,

,

/

,
,

,

(
1-10
10,000
:)



(
DRESS
,
[
,]
Quincke
’
s oedema
[
,
,
)]


,
,
(
,
)


)
"
"
(


,
)
(
,
,
(
)

) "
(

(
)

,
(
)


(
,
)
)
(
,
,
,
,
(
-
)
'
,
-
30%
(
)

(
)
.


(
,
,
,
,
.)
.
(
10,000
:)

.)
( ,
. ,
"
"
(
www.health.gov.il
)
,
:
https://sideeffects.health.gov.il
5
.
?

!
/
.
.

.
.

:
-
25°C
.
6
.
,
:
Croscarmellose sodium, microcrystalline cellulose, povidone, glyceryl
behenate, polyvinyl
alcohol partially hydrolyzed, titanium dioxide (E171), macrogol 3350,
talc, silica colloidal
anhydrous, carnauba wax.
250
Indigo carmine lake (E132)
.
500
Yellow iron oxide (E172)
.
750
Sunset yellow (E110)
,
Red iron oxide (E172)
.
:
250
:
,
,
,
.
500
:
,
,
,
.
750
:
,
,
,
.
1000
:
,
,
,
.
:
60
.
:
"
,
'
1
,
3060000
,
2023
.
:
250
:
149-63-33519-00
500
:
149-64-33518-00
750
: 149-65-33520-00
1000
:
149-66-33514-00
,
.
,
.
:
"
'
21
,
9548402
,